Alaska Hemophilia Association (EIN 943143226) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1990

Legal Domicile

Principal Officer

John Palmatier

Phone

9073439232

Tax Period

2024-01-01 to 2024-12-31

Alaska Hemophilia Association, founded in 1990, is a small nonprofit in the Unknown sector that reported $273K in total revenue in fiscal year 2024. Revenue grew 19% year-over-year, indicating healthy expansion.

Mission

To inform and educate the public about hemophilia and other inherited bleeding disorders, and to provide educational and support services for Alaskans living with hemophilia and other inherited bleeding disorders.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $226,469

Program Service Revenue $0

Investment Income $3,481

Other Revenue $43,442

TOTAL REVENUE $273,392

Expense Breakdown

Grants Paid $0

Salaries & Benefits $133,564

Fundraising Expenses $1,111

Program Expenses $111,950

Other Expenses $144,381

TOTAL EXPENSES $277,945

Year-over-Year Comparison

	2024	2023	Change
Revenue	$273,392	$230,081	+0.2%
Expenses	$277,945	$290,280	0.0%
Net Income	$-4,553	$-60,199	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$111,920

Total Directors

$111,920

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
John Palmatier	Executive Dir.	40.00	Officer Director	$111,920	$0	$111,920
Matthew Findley	President	2.00	Officer Director	$0	$0	$0
Marjorie Allard	Secretary	2.00	Officer Director	$0	$0	$0
Denise Cook	Director	2.00	Director	$0	$0	$0
Wayne Cobb	Treasurer	2.00	Officer Director	$0	$0	$0
Kyme Groller	At-large	3.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$273,392	$277,945	$178,736	$-4,553
2023	$230,081	$290,280	$173,630	$-60,199
2022	$170,037	$219,390	$225,691	$-49,353
2021	$148,288	$157,309	$296,155	$-9,021
2020	$159,009	$114,414	$306,226	$44,595
2019	$203,807	$221,046	$249,158	$-17,239
2018	$208,871	$223,866	$251,392	$-14,995

Alaska Hemophilia Association